FDA Drug Recalls

Recalls / Class II

Class IID-0595-2018

Product

Aripiprazole Tablets, USP, 10 mg, 100 Tablets (10 x 10) unit dose blisters [NDC60687-179-11; UPC (01) 003 60687 179 11 7] per carton (NDC 60687-179-01), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217.

Brand name
Aripiprazole
Generic name
Aripiprazole
Active ingredient
Aripiprazole
Route
Oral
NDCs
60687-157, 60687-168, 60687-179, 60687-191, 60687-202, 60687-213
FDA application
ANDA205064
Affected lot / code info
Lot #: 174096, Exp 05/31/19

Why it was recalled

CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.

Recalling firm

Firm
AMERICAN HEALTH PACKAGING
Manufacturer
American Health Packaging
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2550 John Glenn Ave Ste A, Columbus, Ohio 43217-1188

Distribution

Quantity
270 cartons
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2018-01-19
FDA classified
2018-03-13
Posted by FDA
2018-02-21
Terminated
2019-03-14
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0595-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.